The Journal of Heart and Lung Transplantation
Volume 28, Issue 7 , Pages 683-688, July 2009

Clinical Experience With a New Removable Tracheobronchial Stent in the Management of Airway Complications After Lung Transplantation

Division of Pulmonary, Critical Care and Sleep Medicine, University of Florida Health Science Center, Gainesville, Florida

Received 5 January 2009; received in revised form 13 March 2009; accepted 9 April 2009. published online 08 May 2009.

Background

Airway complications are among the most challenging problems after lung transplantation. This article describes the use of a new tracheobronchial stent that can be placed and removed easily by flexible bronchoscopy.

Methods

A retrospective review was done of 24 consecutive patients requiring tracheobronchial stent placement after lung transplantation. A new self-expanding hybrid nitinol stent was used, and changes in airway diameter and spirometry were assessed. Stent related complications were recorded.

Results

Between February 2007 and April 2008, 24 patients underwent stent placement, and 49 stents were placed for 36 anastomoses at risk. Indications included bronchial stenosis in 12, bronchomalacia in 12, bronchial stenosis plus bronchomalacia in 20, and partial bronchial dehiscence in 5. Adjunctive procedures included electrocautery in 1, balloon dilatation in 7, and electrocautery plus balloon dilatation in 4. The average degree of stenosis decreased from 80% to 20%. After stent placement, the average increase was 0.28 liters in forced vital capacity and 0.44 liters in forced expiratory volume in 1 second. Complications included granulation tissue formation in 10 stents, migration in 9, thick mucus formation in 2, and fracture in 3.

Conclusion

Airway complications in lung transplant patients were effectively palliated. Our complication rate with this new stent is comparable with other airway stents. This stent has the advantage of easy removability during flexible bronchoscopy if complications from the stent outweigh the benefits of palliation.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Dr Jantz has received honorarium from Alveolus Inc and has served on the Alveolus Inc Medical Advisory Board since approximately year 2000. He has received $600 annually for this service from 2000 to 2006. This conflict of interest was reported to our local IRB for this project.

PII: S1053-2498(09)00236-8

doi:10.1016/j.healun.2009.04.014

The Journal of Heart and Lung Transplantation
Volume 28, Issue 7 , Pages 683-688, July 2009